Dual chemotherapy with benznidazole at suboptimal dose plus curcumin nanoparticles mitigates Trypanosoma cruzi-elicited chronic cardiomyopathy
Publication date: Available online 22 November 2020Source: Parasitology InternationalAuthor(s): Matías Hernández, Susana Wicz, Eugenia Pérez Caballero, Miguel H. Santamaría, Ricardo S. Corral
Source: Parasitology International - Category: Parasitology Source Type: research
More News: Cardiology | Cardiomyopathy | Chemotherapy | Heart | Nanotechnology | Parasitology | Turmeric